Remedium Lifecare Ltd

Remedium Lifecare has faced significant volatility, hitting a new 52-week low and experiencing a 13.85% decline over three days. The company has struggled over the past year, with a 90.09% drop, contrasting with the Sensex's positive performance, and is trading below multiple moving averages.

Remedium Lifecare, a microcap trading company, has faced significant stock volatility, hitting a new 52-week low. The stock has declined consecutively over two days and has underperformed its sector. Over the past year, it has experienced a substantial drop, contrasting with the positive performance of the Sensex.

Remedium Lifecare has announced its financial results for the quarter ending December 2024, revealing a significant shift in performance. The company's score has adjusted to -24, indicating challenges that may necessitate a reevaluation of its operational strategies and market conditions within the trading sector.

Remedium Lifecare has faced significant volatility, hitting a new 52-week low and experiencing a 21-day losing streak. The stock has declined 84.39% over the past year, underperforming its sector and trading below key moving averages, highlighting ongoing challenges in the market.

Remedium Lifecare, a microcap trading company, has hit a new 52-week low, reflecting significant volatility and a 33.09% decline over the past three weeks. The stock has dropped 83.69% in the last year, underperforming the Sensex, and is trading below multiple moving averages, indicating ongoing challenges.

Remedium Lifecare has faced significant volatility, reaching a new 52-week low of Rs. 3.79 after 21 consecutive days of decline, resulting in an 83.25% drop over the past year. The stock is trading below all major moving averages, highlighting ongoing challenges in a tough market environment.

Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 33.22% decline over the past 21 days. The company has seen an 83.14% drop in the last year, underperforming its sector and trading below key moving averages, indicating ongoing struggles in the market.

Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 33.22% decline over the past 21 days. The company has seen an 83.14% drop in the last year, underperforming its sector and trading below key moving averages, indicating ongoing struggles in the market.

Remedium Lifecare, a microcap trading company, has faced significant stock volatility, reaching a new 52-week low. Over the past year, it has seen an 82.84% decline, contrasting with the Sensex's gains. The stock is currently trading below multiple moving averages, indicating a persistent downward trend.

Remedium Lifecare has faced significant volatility, reaching a new 52-week low and experiencing a 33.28% decline over the past 21 days. The stock has underperformed its sector and has dropped 82.60% over the past year, contrasting with the Sensex's gains, while trading below key moving averages.

Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 33.28% decline over the past 21 days. The company's performance has deteriorated by 81.93% in the last year, contrasting sharply with the broader market's positive trends, indicating ongoing struggles in the trading sector.

Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 31.97% decline over the past 20 trading days. The company has seen an 81.47% drop in the last year, underperforming its sector and trading below key moving averages, indicating ongoing struggles.

Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 31.97% decline over the past 20 trading days. The company has seen an 81.47% drop in the last year, underperforming its sector and trading below key moving averages, indicating ongoing struggles.

Remedium Lifecare has faced significant volatility, reaching a new 52-week low and experiencing a 30.67% decline over the past 19 days. The stock has underperformed the broader market, with an 81.56% drop over the past year, amid challenges in the trading sector.

Remedium Lifecare has faced significant volatility, reaching a new 52-week low and experiencing a 30.67% decline over the past 19 days. The stock has underperformed the broader market, with an 81.56% drop over the past year, amid challenges in the trading sector.

Remedium Lifecare has faced significant volatility, reaching a new 52-week low and experiencing a 30.67% decline over the past 19 days. The stock has underperformed the broader market, with an 81.56% drop over the past year, amid challenges in the trading sector.

Remedium Lifecare, a microcap trading company, has faced significant volatility, reaching a new 52-week low and experiencing a 26.59% decline over the past 16 trading days. The stock has dropped 81.22% in the past year, contrasting with the broader market's positive performance, highlighting ongoing challenges in its sector.

Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 25.12% decline over the past 15 days. The company has seen an 80.76% drop in the past year, underperforming its sector and trading below key moving averages, indicating ongoing struggles in the market.